SynGenSys’s unique data driven design approach allows rapid assessment of the transcriptional landscape of any target tissue, identification of features contributing to off target expression across all tissues, and parallel assessment of the expression requirements of the transgene.
Our design approach is applicable to gene expression across biopharmaceutical manufacturing, gene therapy, cell therapy and mRNA vaccine development. We build gene expression systems to meet the specific requirements of each application. Best fit, not one size fits all.
Our dedicated expertise and experience in delivering projects for major pharmaceutical and biotech clients ensures your confidence in delivery and outcomes to meet the needs of your project.
Services may be selected in full, or as discrete elements to support individual requirements, development stage timing and resources. Intellectual property is secured as a matter of course throughout the project. Freedom to operate is assured through exclusive licence or assignment of IP to the customer to provide complete clarity and confidence from the outset.
